Brief: Ascentage Pharma Enters Clinical Collaboration With Acerta Pharma
21/06/2020 23:12
June 22 (Reuters) - Ascentage Pharma Group International
6855.HK :
* ENTERED A CLINICAL COLLABORATION WITH ACERTA PHARMA
* WILL SPONSOR TRIAL TO STUDY COMBINATION OF CO'S APG-2575
AND
ACERTA'S CALQUENCE FOR RELAPSED/REFRACTORY CLL/SLL
Source text for Eikon: ID:nHKS2TdqJ0
Further company coverage: 6855.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ascentage Pharma International
See all newsBrief: Ascentage Pharma Group Says Lisaftoclax Granted Breakthrough Therapy Designation In China
China's Ascentage Pharma climbs as chairman buys shares on market
Brief: Ascentage Pharma Group International's Chairman Buys 38,630 Shares
Brief: Ascentage Pharma Group International Posts H1 Net Loss Attributable RMB816.7 Million
China's Ascentage Pharma H1 revenue rises 29% on Lisaftoclax ramp-up